Literature DB >> 16366761

Differences in impulsivity and risk-taking propensity between primary users of crack cocaine and primary users of heroin in a residential substance-use program.

Marina A Bornovalova1, Stacey B Daughters, Gustavo Daniel Hernandez, Jerry B Richards, C W Lejuez.   

Abstract

Crack cocaine use is more associated with impulsivity and a propensity to take risks than heroin use, yet no studies have examined this relationship in the absence of acute drug effects. The current study examined impulsivity (using the Delay Discounting Task) and risk-taking propensity (using the Balloon Analogue Risk Task) across independent groups of primary crack cocaine users with minimal heroin use (n = 16) and primary heroin users with minimal crack cocaine use (n = 11) in residential treatment, with all participants drug abstinent during participation. Crack cocaine users evidenced greater levels of impulsivity and risk-taking propensity, with only the difference in impulsivity persisting after controlling for age and gender. These data hold potential theoretical importance in understanding differences between crack cocaine and heroin users, as the findings cannot be attributed solely to acute pharmacological drug effects. Copyright 2005 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16366761     DOI: 10.1037/1064-1297.13.4.311

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  74 in total

Review 1.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity.

Authors:  Jasmin Vassileva; Stefan Georgiev; Eileen Martin; Raul Gonzalez; Laura Segala
Journal:  Drug Alcohol Depend       Date:  2010-11-26       Impact factor: 4.492

3.  Similar Processes Despite Divergent Behavior in Two Commonly Used Measures of Risky Decision Making.

Authors:  Anthony J Bishara; Timothy J Pleskac; Daniel J Fridberg; Eldad Yechiam; Jesolyn Lucas; Jerome R Busemeyer; Peter R Finn; Julie C Stout
Journal:  J Behav Decis Mak       Date:  2009-10

Review 4.  Impulsivities and addictions: a multidimensional integrative framework informing assessment and interventions for substance use disorders.

Authors:  Jasmin Vassileva; Patricia J Conrod
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

5.  Adolescent risk taking, cocaine self-administration, and striatal dopamine signaling.

Authors:  Marci R Mitchell; Virginia G Weiss; B Sofia Beas; Drake Morgan; Jennifer L Bizon; Barry Setlow
Journal:  Neuropsychopharmacology       Date:  2013-10-22       Impact factor: 7.853

6.  Addictions and Personality Traits: Impulsivity and Related Constructs.

Authors:  Marci R Mitchell; Marc N Potenza
Journal:  Curr Behav Neurosci Rep       Date:  2014-03-01

7.  Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain.

Authors:  Elise N Marino; Kristen D Rosen; Antonio Gutierrez; Maxim Eckmann; Somayaji Ramamurthy; Jennifer Sharpe Potter
Journal:  Addict Behav       Date:  2013-02-04       Impact factor: 3.913

8.  The effect of posttraumatic stress disorder on risk-taking propensity among crack/cocaine users in residential substance abuse treatment.

Authors:  Matthew T Tull; Adria Trotman; Michelle S Duplinsky; Elizabeth K Reynolds; Stacey B Daughters; Marc N Potenza; C W Lejuez
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 9.  Quantifying reinforcement value and demand for psychoactive substances in humans.

Authors:  Adrienne J Heinz; Todd C Lilje; Jon D Kassel; Harriet de Wit
Journal:  Curr Drug Abuse Rev       Date:  2012-12

10.  Disinhibitory psychopathology and delay discounting in alcohol dependence: personality and cognitive correlates.

Authors:  Lyuba Bobova; Peter R Finn; Martin E Rickert; Jesolyn Lucas
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.